DIASYST Inc.
DIASYST helps clinicians make faster, safer medication decisions for patients with chronic diseases like diabetes. It computerizes thousands of pages of clinical guidelines, drug labels, research studies, and best practices into a continuously maintained knowledge base and applies proprietary AI to produce treatment recommendations. The product is offered as a B2B clinical decision support solution for healthcare providers and care teams. Core technologies include natural language processing and AI-driven rules, delivered as a Medication Intelligence platform backed by research from Emory University and the VA.
DIASYST Inc.
DIASYST helps clinicians make faster, safer medication decisions for patients with chronic diseases like diabetes. It computerizes thousands of pages of clinical guidelines, drug labels, research studies, and best practices into a continuously maintained knowledge base and applies proprietary AI to produce treatment recommendations. The product is offered as a B2B clinical decision support solution for healthcare providers and care teams. Core technologies include natural language processing and AI-driven rules, delivered as a Medication Intelligence platform backed by research from Emory University and the VA.